In this edition, we bring you news and Healio-exclusive interviews from the American Neurological Association Annual Meeting. Read the full coverage here: Optimism in older adults improves functional recovery after stroke Neurologic, neurocognitive symptoms of COVID-19 persist for 1 year after diagnosis VIDEO: Functional movement disorders diagnosed on presence of positive criteria Pain, sleep, mood disorders most common comorbidities in patients with narcolepsy VIDEO: Gene therapy potential treatment target for Duchenne muscular dystrophy References: Chamberlain J, et al. Neurogenetics and gene therapy. Presented at: American Neurological Association annual meeting; Oct. 23-25; Chicago. Huff HV, et al. The neurologic and neurocognitive sequelae following COVID-19 in Lima, Peru: Presented at: American Neurological Association annual meeting; Oct. 23-25; Chicago. Lipford MC, et al. Demographic characteristics and comorbidities of patients with narcolepsy: A propensity-score matched cohort study: Presented at: American Neurological Association annual meeting; Oct. 23-25; Chicago. Reich SG, et al. Updates on functional neurological disorders. Presented at: American Neurological Association annual meeting; Oct. 23-25, 2022; Chicago. Sloane KL, et al. Always look on the bright side: Associations of optimism with functional outcomes after stroke. Presented at: American Neurological Association annual meeting; Oct. 23-25; Chicago.

Ver todos los episodios